The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, October 08, 2019
Aethlon announced the FDA has approved its IDE application to initiate an EFS of Hemopurifier® in patients with head and neck cancer in combination ...
read more
Tuesday, September 17, 2019
Sanofi SA, Abbott Laboratories
Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with ...
read more
Monday, September 16, 2019
Gala Therapeutics announced the FDA granted Breakthrough Device Designation for the RheOx Bronchial Rheoplasty system.
read more
Thermo Scientific General Purpose Pro Centrifuge Series has been developed to deliver a safe and regulatory-compliant benchtop separation solution to ...
read more
CVS Health announced the initiation of a clinical trial designed to evaluate the safety and efficacy of the HemoCare™ Hemodialysis System for ...
read more
Abbott announced FDA approval for its new blood and plasma screening Alinity™ s System.
read more
Roche announced FDA 510(k) clearance for the cobas® TV/MG test for use on the cobas® 6800/8800 Systems for the detection of TV and/or MG DNA.
read more
Stryker announced the Premarket Approval (PMA) of the Neuroform Atlas Stent System by the FDA.
read more
Haemonetics announced it received 510(k) clearance from the FDA to expand the medical indication of its TEG® 6s Hemostasis Analyzer System for use in ...
read more
United Therapeutics and DEKA announced receipt of 510(k) clearance by the FDA for the Unity Subcutaneous Delivery System for Remodulin Injection.
read more
Sartorius Stedim Biotech is introducing its new generation of ambr® 15 cell culture automated microbioreactor system.
read more
The U.S. Food and Drug Administration (FDA) permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD).
read more
Thermo Fisher Scientific and Genovis have begun a collaborative research project to develop advanced end-to-end workflows for the preparation, ...
read more
LumiThera has begun enrolling patients in a European Union multi-center clinical study in dry Age-Related Macular Degeneration (AMD) patients.
read more
Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its ...
read more